The content of this website has been produced in line with the INLYTA® (axitinib) Summary of Product Characteristics for Great Britain.
Prescribing Information for INLYTA® (axitinib) click here. Adverse event reporting information can be found at the bottom of the page.
ByYourSideTM is a programme created by Pfizer Oncology that provides tools to help cancer patients manage their lives, regardless of tumour type or stage, as well as resources to support their loved ones. These resources can be downloaded using the QR code below or via the App Store and Google Play Store.
Life with cancer is different for everyone. There are many ways that patients go about their lives after a diagnosis. Patients can visit ByYourSide™ to read inspiring stories of hope, determination and
generosity.
Patients can visit ByYourSide.co.uk or download the ByYourSideTM app to browse articles and resources designed to help them navigate and manage life with cancer.
Help your patients connect to their wellbeing with articles on relationships, nutrition, fitness and more.
Discover more about how ByYourSideTM can help your patients
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
No
OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?